 |
AstraZeneca heart drug wins Canada approvalCanadian regulators have approved AstraZeneca's key new heart drug Brilinta, boosting prospects for a product whose future in North America is uncertain. The green light from Health Canada means the medicine is now approved in 33 countries More… |
Thursday 18 April 2024
